March 8 (Reuters) - Cell Therapeutics Inc:
* FDA approves nerpharma to manufacture Cell therapeutics' drug pixantrone
* Says cti has a new drug application under review at the FDA for pixantrone
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* FDA approves nerpharma to manufacture Cell therapeutics' drug pixantrone
* Says cti has a new drug application under review at the FDA for pixantrone
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2010 AFX News
